Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment selection in the clinical practice of systemic lupus erythematosus: results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A, Kawano S, Nishimura N, Kashiwado Y, Doi G, Nakayama T, Fukumoto R, Tsuru T, Suzaki M, Akahoshi M, Maekawa M, Omoto A, Tada H, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: ota si. Mod Rheumatol. 2024 Aug 3:roae058. doi: 10.1093/mr/roae058. Online ahead of print. Mod Rheumatol. 2024. PMID: 39096517
The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
Ono N, Inoue Y, Miyamura T, Ueda N, Nagano S, Inoue H, Oryoji K, Ota SI, Sawabe T, Yoshizawa S, Takeyama Y, Sadanaga Y, Takamori A, Kimoto Y, Miyake K, Horiuchi T, Nakashima H, Niiro H, Tada Y. Ono N, et al. Among authors: ota si. J Rheumatol. 2021 Mar;48(3):417-425. doi: 10.3899/jrheum.190373. Epub 2019 Sep 15. J Rheumatol. 2021. PMID: 31523048
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan.
Takeyama Y, Ono N, Shirahama Y, Inoue Y, Tanaka A, Ueda N, Nishimura N, Nagano S, Uchino A, Miyamura T, Oryoji K, Inoue H, Maruyama A, Ota SI, Yoshizawa S, Sawabe T, Himuro N, Miyake K, Kimoto Y, Horiuchi T, Mitoma H, Niiro H, Takamori A, Tada Y. Takeyama Y, et al. Among authors: ota si. Mod Rheumatol. 2021 Mar;31(2):408-416. doi: 10.1080/14397595.2020.1790778. Epub 2020 Jul 27. Mod Rheumatol. 2021. PMID: 32615836
Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.
Kashiwado Y, Kiyohara C, Kimoto Y, Nagano S, Sawabe T, Oryoji K, Mizuki S, Nishizaka H, Yoshizawa S, Yoshizawa S, Tsuru T, Inoue Y, Ueda N, Ota SI, Suenaga Y, Miyamura T, Tada Y, Niiro H, Akashi K, Horiuchi T. Kashiwado Y, et al. Among authors: ota si. Arthritis Res Ther. 2022 Jun 1;24(1):131. doi: 10.1186/s13075-022-02820-y. Arthritis Res Ther. 2022. PMID: 35650638 Free PMC article.
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, Ariyama H, Kusaba H, Niiro H, Akashi K, Baba E. Yamaguchi K, et al. Among authors: ota si. Cancer Sci. 2018 Oct;109(10):3032-3042. doi: 10.1111/cas.13758. Epub 2018 Aug 31. Cancer Sci. 2018. PMID: 30066977 Free PMC article. Clinical Trial.
Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.
Inadomi K, Kumagai H, Arita S, Tsuruta N, Takayoshi K, Mishima K, Ota SI, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Uchi H, Yamamoto H, Ariyama H, Kusaba H, Niiro H, Oda Y, Akashi K, Baba E. Inadomi K, et al. Among authors: ota si. Medicine (Baltimore). 2016 Jul;95(29):e4283. doi: 10.1097/MD.0000000000004283. Medicine (Baltimore). 2016. PMID: 27442668 Free PMC article.
13 results